Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

7.98
Delayed Data
As of Sep 28
 0.00 / 0.00%
Today’s Change
5.60
Today|||52-Week Range
8.29
+5.84%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.98
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)5,707
Market cap$33.4M
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio25.7
Price/Sales2.32
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
VTGNVistaGen Therapeutic...+0.02+0.47%
CLSNCelsion Corp-0.00-0.13%
CURNeuralstem Inc+0.00+0.60%
ORPNBioblast Pharma Ltd-0.02-1.14%
Data as of 11:39am ET, 09/29/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Search for Jobs